Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

被引:0
作者
Joanne Kotsopoulos
Jan Lubinski
Henry T. Lynch
Jan Klijn
Parviz Ghadirian
Susan L. Neuhausen
Charmaine Kim-Sing
William D. Foulkes
Pal Moller
Claudine Isaacs
Susan Domchek
Susan Randall
Kenneth Offit
Nadine Tung
Peter Ainsworth
Ruth Gershoni-Baruch
Andrea Eisen
Mary Daly
Beth Karlan
Howard M. Saal
Fergus Couch
Barbara Pasini
Teresa Wagner
Eitan Friedman
Gad Rennert
Charis Eng
Jeffrey Weitzel
Ping Sun
Steven A. Narod
机构
[1] Women’s College Hospital,Centre for Research in Women’s Health
[2] University of Toronto,Department of Nutritional Sciences
[3] University of Toronto,Hereditary Cancer Center
[4] Pomeranian Medical University,Department of Preventive Medicine and Public Health
[5] Creighton University School of Medicine,Department of Medical Oncology
[6] Rotterdam Cancer Institute,Epidemiology Research Unit, Research Centre
[7] Centre Hospitalier de l’Universitaire Montréal,Département de Nutrition
[8] CHUM Hôtel Dieu,Epidemiology Division, Department of Medicine
[9] Faculte du Medicine,Departments of Medicine, Human Genetics, and Oncology
[10] University of Montreal,Department of Cancer Genetics
[11] University of California,Lombardi Cancer Center
[12] British Columbia Cancer Agency,Departments of Hematology and Oncology
[13] McGill University,Department of Gynecologic Oncology
[14] Norwegian Radium Hospital,Department of Human Genetics and Medicine
[15] Georgetown University Medical Center,Institute of Genetics
[16] University of Pennsylvania,Division of Population Science
[17] Princess Margaret Hospital,Hereditary Cancer Program, Division of Human Genetics
[18] Memorial Sloan-Kettering Cancer Center,Section of Genetics
[19] Beth Israel Deaconess Medical Center,Division of Senology, Department of Gynecology
[20] London Regional Program,The Suzanne Levy Gertner Oncogenetics Unit
[21] London Health Sciences Centre,The Sackler School of Medicine
[22] Rambam Medical Center,Clinical Cancer Genetics Program, Comprehensive Cancer Center, Division of Human Genetics, Department of Internal Medicine
[23] Toronto-Sunnybrook Regional Cancer Center,Genomic Medicine Institute
[24] Fox Chase Cancer Center,Department of Cancer Genetics
[25] Gynecology Oncology,undefined
[26] Cedars Sinai Medical Center,undefined
[27] Children’s Hospital Medical Center,undefined
[28] Mayo Clinic,undefined
[29] University of Turin,undefined
[30] Medical University of Vienna,undefined
[31] Private Trust for Breast Health,undefined
[32] The Chaim Sheba Medical Center,undefined
[33] Tel-Aviv University,undefined
[34] National Cancer Control Center,undefined
[35] Carmel Medical Center,undefined
[36] The Ohio State University,undefined
[37] Cleveland Clinic Foundation,undefined
[38] City of Hope National Medical Center,undefined
来源
Breast Cancer Research and Treatment | 2007年 / 105卷
关键词
Age at first birth; Breast cancer; Case–control study;
D O I
暂无
中图分类号
学科分类号
摘要
An early age at first full-term birth is associated with a reduction in the subsequent development of breast cancer among women in the general population. A similar effect has not yet been reported among women who carry an inherited BRCA1 or BRCA2 mutation. We conducted a matched case–control study on 1816 pairs of women with a BRCA1 (n = 1405) or BRCA2 (n = 411) mutation in an attempt to elucidate the relationship between age at first full-term pregnancy and the risk of developing breast cancer. Information about the age at first childbirth and other pregnancy-related variables was derived from a questionnaire administered to women during the course of genetic counselling. There was no difference in the mean age at first full-term birth in the cases and controls (24.9 years vs. 24.8 years; P = 0.81, respectively). Compared to women whose first child was born at or before 18 years of age, a later age at first full-term birth did not influence the risk of developing breast cancer (OR = 1.00 per year; 95% CI 0.98–1.03; P-trend = 0.67). Stratification by mutation status did not affect the results. These findings suggest that an early first full-term birth does not confer protection against breast cancer in BRCA mutation carriers. Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective.
引用
收藏
页码:221 / 228
页数:7
相关论文
共 92 条
[1]  
Pike MC(1983)‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer Nature 303 767-770
[2]  
Krailo MD(1993)Reproductive factors and breast cancer Epidemiol Rev 15 36-47
[3]  
Henderson BE(2001)Epidemiology of breast cancer Lancet Oncol 2 133-140
[4]  
Kelsey JL(1970)Age at first birth and breast cancer risk Bull World Health Organ 43 209-221
[5]  
Gammon MD(2000)Age at any full-term pregnancy and breast cancer risk Am J Epidemiol 151 715-722
[6]  
John EM(1983)Reproductive factors in the aetiology of breast cancer Br J Cancer 47 757-762
[7]  
Key TJ(1989)The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group J Clin Epidemiol 42 963-973
[8]  
Verkasalo PK(1998)Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 676-689
[9]  
Banks E(2003)Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117-1130
[10]  
MacMahon B(1993)Increasing incidence of breast cancer in family with BRCA1 mutation Lancet 341 1101-1102